Skip to main content
OpenTrials

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

3,496 public trials 645 recruiting studies
Refine in advanced search Browse all conditions

Synucleinopathies trial results

Completed

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

NCT00363727

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • GSK Investigational Site Anniston, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 69 locations
View Trial Details
Completed

Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease

NCT00823836

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
View all 54 locations
View Trial Details

Related conditions